Genetic testing is attracting attention as a technology that analyzes an individual’s genetic information to reveal their health condition, disease risk, and physical constitution. However, it has been pointed out that the accuracy and reliability of genetic testing varies depending on the type of test and provider. This article focuses on the accuracy and reliability of genetic testing and provides a detailed explanation, including the latest research results and expert opinions. kitasato-u.ac.jp
1. Types and Purposes of Genetic Testing
Genetic testing is carried out for three main purposes:
Disease diagnosis : A test to check for the presence or absence of a disease caused by a specific gene mutation. For example, it is used to diagnose hereditary diseases and some cancers .
Disease risk assessment : This is a test to assess the risk of developing a specific disease in the future. This includes risk assessment of lifestyle-related diseases and allergies.
Understanding individual constitution and characteristics : This is a test to find out individual constitution and characteristics such as obesity tendency, alcohol metabolism ability, skin type, etc.
2. Factors that affect the accuracy of genetic testing
The accuracy of a genetic test depends on the following factors:
Accuracy of the test method : The accuracy of the test results varies depending on the analytical technology and equipment used. For example, next-generation sequencing (NGS) technology is considered to have high accuracy. hiro-clinic.or.jp+1Ministry of Health, Labor and Welfare Grant+1
Scientific evidence of the test items : It is important that the relationship between the genetic polymorphisms or mutations to be analyzed and the risk of disease has been thoroughly researched. If the scientific evidence is lacking, the reliability of the results will be reduced .
Quality control system of the testing institution : Whether the institution conducting the test has appropriate quality control and is third-party certified also affects the reliability of the results.
3. Current status and challenges of direct-to-consumer genetic testing (DTC genetic testing)
In recent years, there has been an increase in Direct-to-Consumer (DTC) genetic tests that individuals can apply for directly without going through a medical institution. These tests are gaining popularity as a convenient way to know one’s genetic information, but the following issues have been pointed out. jstage.jst.go.jp+2kitasato-u.ac.jp+2Drug Window+2
Lack of scientific evidence : Some DTC genetic tests have limited data to interpret the results, and the scientific evidence may be insufficient .
Lack of transparency in quality control : The quality control system of the institution conducting the test and the qualifications of the experts involved in interpreting the test results may not be clearly stated.
Lack of interpretation of results and aftercare : There may be insufficient support on how to interpret test results and apply them to daily life. In particular, the lack of specialized support such as genetic counseling is a problem.
4. Initiatives to improve the reliability of genetic testing
The following efforts are being made to improve the reliability of genetic testing:
Promoting third-party certification : The introduction of a third-party certification system to evaluate the quality and capabilities of testing organizations is being considered. This is expected to ensure the reliability of testing results.
Training and certification of personnel : Efforts are being made to improve the quality of testing through training and certification of experts involved in testing. This is expected to lead to proper interpretation of test results and explanation to users. kitasato-u.ac.jp
5. Current status of quality control and regulations for genetic testing
In order to ensure the quality and reliability of genetic tests, it is essential that each country has its own regulations and quality control standards. In particular, the standards that apply to clinical genetic tests conducted at medical institutions and direct-to-consumer genetic tests (DTC genetic tests) differ.
5.1 Regulations regarding genetic testing in medical institutions
Genetic testing conducted at medical institutions is primarily used to diagnose disease and determine treatment plans, so strict standards apply. For example, the following regulations exist in Japan:
Clinical Laboratory Technologist Act : Stipulates the qualifications of technicians who perform genetic testing
Ministry of Health, Labor and Welfare guidelines : Recommendation for appropriate testing based on clinical genetics
Ethics review required : Some genetic tests require approval from an ethical committee
Additionally, different countries apply different regulations, such as the US Food and Drug Administration approving certain genetic tests and the EU requiring CE marking.
5.2 Regulations and challenges of DTC genetic testing
While DTC genetic testing is easy for general consumers to use, the regulatory framework may not be fully established. For example, in Japan, there are no clear laws governing DTC genetic testing, and it is left to the discretion of each business operator to set their own standards.
On the other hand, in the United States, the FDA restricts the sale of some DTC genetic tests, and controls are in place to ensure that only reliable tests are available on the market. However, complete quality assurance is not yet available, and users must thoroughly verify the information themselves.
6. Measures to improve the reliability of genetic testing
To improve the reliability of genetic testing, the following measures are necessary:
6.1 Providing scientifically based testing
For the results of genetic testing to be reliable, it is important that the scientific evidence is well established. In particular, it is desirable that the following elements are present:
Analysis based on large-scale research data : Reliable genetic testing is based on the results of large-scale genomic research, such as research using methods such as GWAS (genome-wide association study).
Reproducible results : Whether stable results are obtained when analyzing the same gene under the same conditions is also an important indicator.
6.2 Introduction of a third-party certification system
To objectively evaluate the quality of genetic testing, it is effective to introduce a certification system by a third-party organization. For example, the following certification organizations exist:
College of American Pathologists (CAP) : Audits quality control in clinical laboratories
CLIA (Clinical Laboratory Improvement Act) : Standards that apply to clinical laboratories in the United States
ISO 15189 : International standard for ensuring the quality and competence of clinical laboratories
6.3 Proper interpretation of test results and provision of counselling
Since the results of genetic testing are often difficult for ordinary consumers to understand, they require appropriate explanations from experts. In particular, it is necessary to clarify the following points:
What the results mean (relative risk vs. absolute risk)
Influence of genetic and environmental factors
Avoid misleading statements (e.g., state statistical probability rather than simply saying “high risk of cancer”)
7. The future of genetic testing and future challenges
As genetic analysis technology evolves, more accurate and comprehensive genetic testing is becoming possible, but at the same time, ethical and legal issues have arisen that require careful consideration.
7.1 Protecting the privacy of genetic information
Genetic information is highly personal data, and its improper management increases the risk of privacy violations. The following points in particular are of concern:
Provision of genetic information to third parties: Insurance companies and employers may obtain genetic information and use it for discrimination
Risk of data leakage: Leakage of genetic data due to hacking or unauthorized access
For this reason, there is an urgent need to establish laws regarding the handling of genetic information. For example, the United States has enacted the Genetic Information Nondiscrimination Act (GINA), which prohibits discrimination based on genetic information.
7.2 Use of AI technology and ethical issues
In recent years, genetic analysis using AI technology has progressed, making it possible to assess the risk of each individual more precisely. However, when AI algorithms become black boxes, the following problems can occur:
The impact of bias : If the dataset that AI learns from is biased, it may produce inaccurate results.
Lack of accountability : It will be difficult to explain why an AI has reached a certain conclusion.
For this reason, when utilizing AI technology, it is necessary to ensure transparency and establish an appropriate audit system.
8. Advances in genetic testing and personalized medicine
Genetic testing goes beyond simply assessing disease risk and plays an important role in realizing personalized medicine. It is now possible to select optimal treatments and drugs based on an individual’s genetic information, improving the precision of medical care.
8.1 Use of genetic testing in cancer treatment
Genetic testing is having a particularly large impact on cancer treatment. Understanding a tumor’s genetic profile offers the following benefits:
Selection of targeted therapy: Conventional cancer treatments have mainly been chemotherapy and radiation therapy. However, genetic testing has made it possible to identify mutations specific to cancer cells and select molecular targeted drugs accordingly. For example, trastuzumab (Herceptin) is considered effective for patients with HER2-positive breast cancer.
Determining whether immunotherapy is appropriate: Cancer immunotherapy has been attracting attention in recent years, but it is not effective for all patients. Genetic testing can measure biomarkers such as PD-L1 and TMB (tumor mutation burden) to determine whether immune checkpoint inhibitors are appropriate.
Predicting treatment efficacy and avoiding side effects: Based on genetic information, it is possible to assess in advance whether a particular drug is likely to be effective or whether there is a high risk of serious side effects.
8.2 Genetic testing and drug selection (pharmacogenomics)
Pharmacogenomics is a field that predicts the effectiveness and side effects of drugs based on an individual’s genetic information and selects the most appropriate drug. The following are some well-known examples:
Dose adjustment of the anticoagulant warfarin : Warfarin is a blood-thinning drug, but its effectiveness and bleeding risk can vary greatly depending on differences in genes such as CYP2C9 and VKORC1. Genetic testing can be used to determine the appropriate dosage for each individual patient.
Managing side effects of the anti-cancer drug irinotecan : Some patients have a reduced ability to metabolize irinotecan due to mutations in the UGT1A1 gene, which can cause severe side effects. By conducting a genetic test in advance, the dosage can be adjusted and side effects can be reduced.
8.3 Risk assessment and preventive medicine for lifestyle-related diseases
Genetic testing is used not only for cancer and drug selection, but also for evaluating the risk of lifestyle-related diseases. For example, it is possible to evaluate the risk of the following diseases:
Diabetes: Mutations in the TCF7L2 gene are known to be associated with the risk of developing type 2 diabetes.
High blood pressure: Polymorphisms in the AGT (angiotensinogen) gene are believed to increase the risk of high blood pressure.
Obesity: Mutations in the FTO gene have been reported to influence obesity tendency.
By utilizing this information, it would be possible to provide early intervention and appropriate dietary and exercise advice to those at high genetic risk.
9. Ethical and social issues of genetic testing
While genetic testing technology advances, ethical and social issues have also emerged. In particular, issues regarding the handling of genetic information require careful discussion.
9.1 Risk of genetic discrimination
There are concerns that the results of genetic testing may affect employment, insurance contracts, etc. For example, the following problems may be considered:
Discrimination in employment : Companies could obtain genetic information about employees and avoid hiring people who are at high risk of disease.
Restrictions on insurance contracts: When applying for life or medical insurance, your genetic information may be taken into consideration, which could result in higher premiums or even denial of coverage.
To prevent such risks, the United States has enacted the Genetic Information Nondiscrimination Act (GINA), which prohibits discrimination on the basis of genetic information. Japan is also calling for the establishment of a similar law.
9.2 Ethical issues within families
Genetic testing can have impacts on individuals as well as families: for example, knowing the risk of a genetic disease can create psychological stress within family members.
Risk of sharing genetic information without family consent
Ethical issues regarding prenatal testing (e.g., whether selective abortion based on genetic testing of the fetus is appropriate)
Adequate counselling and guidelines need to be put in place to address these issues.
10. Future Outlook for Genetic Testing
It is expected that genetic testing technology will continue to develop in the future, leading to an expansion into new fields of application.
10.1 The spread of whole genome analysis
Conventional genetic testing typically analyzes only specific genes, but advances in next-generation sequencing (NGS) have made it possible to perform whole-genome analysis at low cost, enabling more comprehensive analysis of genetic information.
10.2 Integration with gene editing technology
Combined with gene editing techniques such as CRISPR-Cas9, it may be possible to correct genetic abnormalities, which is expected to revolutionize the treatment of genetic diseases.
10.3 Utilizing AI and Big Data
Analysis of genetic information using AI will enable more accurate disease prediction and treatment options. In particular, combining it with big data analysis is expected to accelerate the progress of personalized medicine.
11. New possibilities for genetic testing and health management
Advances in genetic testing are revolutionizing our approach to personal health management and preventive medicine, particularly in the use of genetic information for lifestyle optimization and disease prevention.
11.1 Genetic testing and nutritional management (nutrigenomics)
Nutrigenomics is a field of study that designs optimal nutritional intake for each individual based on genetic information, which enables more effective dietary advice and supplement recommendations.
For example, the following genetic factors influence nutritional management:
Caffeine metabolism: Due to differences in the CYP1A2 gene, some people metabolize caffeine quickly and others slowly. Slow metabolizers can improve their sleep quality by limiting their caffeine intake.
Lactose intolerance: Mutations in the LCT gene determine whether or not a person can digest lactose. People with lactose intolerance can reduce their digestive symptoms by avoiding dairy products.
Metabolism of omega-3 fatty acids: Mutations in the FADS1 gene affect the body’s ability to synthesize DHA and EPA, making it possible to take measures such as increasing fish intake if necessary.
In this way, genetic testing can be used to achieve more individualized nutritional management.
11.2 Sports performance and genetic testing
In the field of sports science, genetic testing is also being used to optimize training programs. Muscle composition and endurance characteristics are determined to some extent by genes, and can be used as an indicator to determine the direction of training.
For example, the following genes are involved in athletic ability:
ACTN3 gene: A gene involved in fast-twitch muscle fibers (explosive power), with genotypes suitable for sprint events and power sports.
PPARGC1A gene: A gene involved in endurance that can determine whether or not someone has a physique suited to marathons and long-distance running.
ACE gene: A gene that influences blood pressure regulation and muscle recovery ability and is involved in training adaptation.
Based on this information, it is possible to create an appropriate training menu and improve the performance of each individual athlete.
12. Social acceptance of genetic testing and future challenges
As genetic testing becomes more widespread in society, there is growing discussion about its acceptance and challenges. In particular, how ordinary consumers perceive and use genetic information is an important issue.
12.1 Raising consumer awareness and understanding
For genetic testing to become more widespread, it is essential that consumers have the appropriate knowledge and correctly understand the results. However, the following problems have been identified at present:
Misunderstanding of results : Although the results of genetic tests are probabilistic and do not conclusively state whether or not a person will develop a particular disease, some consumers may mistakenly believe that the results are an absolute diagnosis.
Excessive expectations and anxiety : While some people become excessively anxious after learning about the health risks through genetic testing, others may feel a false sense of security, thinking, “I’m fine because I have this gene.”
To address these issues, it is necessary to develop educational programs about genetic testing so that consumers can interpret the information appropriately.
12.2 Development of legal and ethical frameworks
As the use of genetic testing becomes more widespread, there is also a need to establish legal and ethical frameworks.
Protection of data privacy : Genetic information is extremely personal and requires strict management to prevent inappropriate use. In particular, it is important to establish laws to prevent the risk of user data of DTC genetic testing services being provided to third parties without permission.
The pros and cons of commercial use of genetic information : Ethical issues when companies use genetic information in marketing and product development. A mechanism is needed for consumers to give their consent after receiving sufficient information.
13. Future outlook for the fusion of genetic testing and technology
It is expected that genetic testing technology will continue to evolve in the future, opening up new possibilities.
13.1 Collaboration with wearable devices
Currently, wearable devices such as smartwatches and fitness trackers are widespread, and it is believed that in the future it will be possible to combine these with genetic information to manage health.
Exercise and diet advice based on genetic information
Real-time health risk assessment (e.g., blood sugar management support for people with a genetically high risk of diabetes)
13.2 The spread of personalized preventive medicine
In the future, we believe we will see an era in which genetic information will be utilized to provide each individual with the optimal health management plan.
Providing completely individualized supplements
Personalized medicine based on genetic data
In this way, it is expected that the combination of genetic testing with the latest technology will lead to more advanced health management and medical care.
Summary
Genetic testing is a technology that is useful for assessing disease risk and realizing personalized medicine, but various factors affect its accuracy and reliability. The type of test, analysis method, and quality control of the provider determine the accuracy of the results. In particular, direct-to-consumer (DTC) genetic tests are easy to use, but they face challenges such as a lack of scientific evidence and difficulty in interpretation.
Meanwhile, in the medical field, genetic testing is being used in cancer treatment and drug selection, making it possible to select more effective treatments. In nutritional management and sports science, individual optimization based on genetic information is also progressing. However, protecting the privacy of genetic information and ethical issues are also important, and appropriate legislation and education are required.
In the future, it is expected that the accuracy and convenience of genetic testing will improve through the fusion of AI and big data, and through linkage with wearable devices. As costs are reduced and security measures are improved, a future in which anyone can safely use genetic information will become a reality.
